Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon receptor | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon receptor | 477 aa | 457 aa | 25.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | Serine\/threonine protein kinase homolog | 0.0176 | 1 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.2627 | 0.2627 |
Trypanosoma brucei | Casein kinase II | 0.0075 | 0.3558 | 0.5 |
Echinococcus granulosus | casein kinase ii subunit alpha | 0.0075 | 0.3558 | 0.3558 |
Leishmania major | casein kinase II, putative | 0.0075 | 0.3558 | 0.5 |
Brugia malayi | Casein kinase II, alpha chain | 0.0075 | 0.3558 | 0.3558 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.1411 | 0.1411 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0176 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.1411 | 0.1411 |
Loa Loa (eye worm) | CAMK/PIM protein kinase | 0.0176 | 1 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.1411 | 0.1411 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0075 | 0.3558 | 0.5 |
Trypanosoma cruzi | casein kinase II, putative | 0.0075 | 0.3558 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0075 | 0.3558 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0075 | 0.3558 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0075 | 0.3558 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0075 | 0.3558 | 0.5 |
Plasmodium vivax | unspecified product | 0.0075 | 0.3558 | 0.5 |
Loa Loa (eye worm) | CMGC/CK2 protein kinase | 0.0075 | 0.3558 | 0.3558 |
Echinococcus multilocularis | proto oncogene serine:threonine protein kinase | 0.0176 | 1 | 1 |
Loa Loa (eye worm) | CAMK/PIM protein kinase | 0.0176 | 1 | 1 |
Brugia malayi | Serine/threonine-protein kinase Pim-3 | 0.0176 | 1 | 1 |
Loa Loa (eye worm) | CAMK/CAMKL/PASK protein kinase | 0.0095 | 0.4873 | 0.4873 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0075 | 0.3558 | 0.5 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.2627 | 0.2627 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.2627 | 0.2627 |
Echinococcus granulosus | proto oncogene serine:threonine protein kinase | 0.0176 | 1 | 1 |
Plasmodium falciparum | casein kinase 2, alpha subunit | 0.0075 | 0.3558 | 0.5 |
Echinococcus multilocularis | casein kinase ii subunit alpha | 0.0075 | 0.3558 | 0.3558 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.2627 | 0.2627 |
Toxoplasma gondii | CMGC kinase, CK2 family | 0.0075 | 0.3558 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0075 | 0.3558 | 0.5 |
Plasmodium vivax | casein kinase 2, alpha subunit, putative | 0.0075 | 0.3558 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0075 | 0.3558 | 0.5 |
Giardia lamblia | Kinase, CMGC CK2 | 0.0075 | 0.3558 | 0.5 |
Entamoeba histolytica | casein kinase, putative | 0.0075 | 0.3558 | 0.5 |
Schistosoma mansoni | protein kinase | 0.0075 | 0.3558 | 0.3558 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Kb (binding) | = 15000 nM | Antagonist activity at human glucagon receptor assessed as inhibition of glucagon-induced cAMP production by cell based assay in presence of 4% bovine serum albumin | ChEMBL. | 23562063 |
Ki (binding) | = 1300 nM | Displacement of [125I]-glucagon-cex from human glucagon receptor by cell based assay in presence of 0.2% bovine serum albumin | ChEMBL. | 23562063 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.